Dual Targeting of HDM2 and PPM1D As a Novel Therapeutic Approach for Myelofibrosis

被引：0
|
作者：
Marcellino, Bridget K. [1 ]
Clementelli, Cara [2 ]
Beaumont, Kristin [3 ]
Schaniel, Christoph [2 ]
Lu, Min [4 ]
Chen, Karie [2 ]
Russel, Adena [2 ]
Mohammad, Ayman [2 ]
Nathan, Daniel I. [2 ]
Aronin, Jake [2 ]
Shih, Alan H. [2 ]
Sebra, Robert [3 ]
Hoffman, Ronald [2 ,5 ]
机构：
[1] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Tisch Canc Inst, New York, NY 10029 USA
[3] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA
[4] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Tisch Canc Inst, Elmhurst, NY USA
[5] MPN Res Consortium, New York, NY USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-170232
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] TRPM2-AS promotes the malignancy of osteosarcoma cells by targeting miR-15b-5p/PPM1D axis
    Cai, Yingchun
    Yang, Yudan
    Zhang, Xudong
    Ma, Qingqing
    Li, Mengyi
    CELL CYCLE, 2022, 21 (08) : 835 - 850
  • [32] PPM1D430, a Novel Alternative Splicing Variant of the Human PPM1D, can Dephosphorylate p53 and Exhibits Specific Tissue Expression
    Chuman, Yoshiro
    Kurihashi, Wataru
    Mizukami, Yohei
    Nashimoto, Takehiro
    Yagi, Hiroaki
    Sakaguchi, Kazuyasu
    JOURNAL OF BIOCHEMISTRY, 2009, 145 (01): : 1 - 12
  • [33] Phosphatase magnesium-dependent 1 δ (PPM1D), serine/threonine protein phosphatase and novel pharmacological target in cancer
    Nahta, Rita
    Castellino, Robert Craig
    BIOCHEMICAL PHARMACOLOGY, 2021, 184
  • [34] Novel 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists with improved cellular activity
    Leonard, Kristi
    Marugan, Juan Jose
    Raboisson, Pierre
    Calvo, Raul
    Gushue, Joan M.
    Koblish, Holly K.
    Lattanze, Jennifer
    Zhao, Shuyuan
    Cummings, Maxwell D.
    Player, Mark R.
    Maroney, Anna C.
    Lu, Tianbao
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (13) : 3463 - 3468
  • [35] Protein phosphatase, Mg2+/Mn2+-dependent 1D (PPM1D) mutations in haematological cancer
    Husby, Simon
    Justesen, Emma Hjermind
    Gronbaek, Kirsten
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (04) : 697 - 705
  • [36] The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase
    M Oliva-Trastoy
    V Berthonaud
    A Chevalier
    C Ducrot
    M-C Marsolier-Kergoat
    C Mann
    F Leteurtre
    Oncogene, 2007, 26 : 1449 - 1458
  • [37] The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase
    Oliva-Trastoy, M.
    Berthonaud, V.
    Chevalier, A.
    Ducrot, C.
    Marsolier-Kergoat, M-C
    Mann, C.
    Leteurtre, F.
    ONCOGENE, 2007, 26 (10) : 1449 - 1458
  • [38] Novel truncating variant of PPM1D penultimate exon in a Chinese patient with Jansen-de Vries syndrome
    Li, Zhuoguang
    Du, Caiqi
    Zhang, Cai
    Zhang, Mini
    Ying, Yanqin
    Liang, Yan
    Luo, Xiaoping
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (03):
  • [39] Structure-based design, synthesis, and biological evaluation of novel 1,4-diazepines as HDM2 antagonists
    Raboisson, P
    Marugán, JJ
    Schubert, C
    Koblish, HK
    Lu, TB
    Zhao, SY
    Player, MR
    Maroney, AC
    Reed, RL
    Huebert, ND
    Lattanze, J
    Parks, DJ
    Cummings, MD
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (07) : 1857 - 1861
  • [40] Molecular Profiling of Grade III Invasive Ductal Breast Cancers Identifies PPM1D Amplification as a Therapeutic Target in Luminal and HER2 Tumours
    Natrajan, R.
    Rodriguez-Pinilla, S. M.
    Lambros, M. B. K.
    Tan, D. S. P.
    Marchio, C.
    Vatcheva, R.
    Rayter, S.
    Moreno-Bueno, G.
    Fulford, L. G.
    Mackay, A.
    Grigoriadis, A.
    Fenwick, K.
    Tamber, N.
    Hardisson, D.
    Tutt, A.
    Palacios, J.
    Buerger, H.
    Lord, C. J.
    Ashworth, A.
    Reis-Filho, J. S.
    MODERN PATHOLOGY, 2009, 22 : 59A - 59A
12345